Prediction of myocardial tissue loss by quantitative densitometric myocardial blush parameters following ST-elevation

V Sasi1, H Gavallér, A Kalapos

  • 1Division of Invasive Cardiology, Department of Cardiology, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged , Szeged , Hungary.

Insights

Myocardial perfusion assessed by videodensitometry after ST-elevation myocardial infarction (STEMI) can predict late tissue loss. This quantitative method offers a feasible approach for assessing prognosis after revascularization therapy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Tissue-level myocardial perfusion is a critical prognostic factor in acute ST-elevation myocardial infarction (STEMI) patients post-recanalization.
  • Assessing perfusion directly after revascularization is crucial for predicting long-term outcomes.

Purpose of the Study:

  • To investigate the relationship between videodensitometric myocardial perfusion parameters from coronary angiography and magnetic resonance imaging (MRI)-derived myocardial tissue loss late after STEMI.
  • To evaluate the predictive value of G(max)/T(max) for myocardial tissue loss.

Main Methods:

  • The study included 29 STEMI patients undergoing successful recanalization therapy.
  • Videodensitometric parameter G(max)/T(max) was calculated from coronary angiograms.
  • Myocardial Loss Index (MLI) was assessed using cardiac MRI at approximately 376 days post-PCI.

Main Results:

  • Significant correlations were found between MLI and G(max) (r = 0.36, p = 0.05) and G(max)/T(max) (r = 0.40, p = 0.03).
  • Receiver operating characteristic curve analysis indicated that G(max)/T(max) < 2.17 predicted MLI values of 0.3-0.6 with good sensitivity and specificity.
  • G(max)/T(max) < 3.25 showed prognostic value for predicting MLI = 0.7.

Conclusions:

  • Quantitative measurement of myocardial tissue-level perfusion using videodensitometry is feasible.
  • This method serves as a valuable predictor of myocardial tissue loss following STEMI and revascularization.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
451
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K